ATE490761T1 - Augentropfen - Google Patents

Augentropfen

Info

Publication number
ATE490761T1
ATE490761T1 AT01965597T AT01965597T ATE490761T1 AT E490761 T1 ATE490761 T1 AT E490761T1 AT 01965597 T AT01965597 T AT 01965597T AT 01965597 T AT01965597 T AT 01965597T AT E490761 T1 ATE490761 T1 AT E490761T1
Authority
AT
Austria
Prior art keywords
prostaglandin derivatives
water
liable
ophthalmic solutions
eye drop
Prior art date
Application number
AT01965597T
Other languages
English (en)
Inventor
Kenji Morishima
Akio Kimura
Hiroyuki Asada
Masayuki Umeda
Mitsuaki Kuwano
Original Assignee
Santen Pharmaceutical Co Ltd
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18762864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE490761(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Santen Pharmaceutical Co Ltd, Asahi Glass Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE490761T1 publication Critical patent/ATE490761T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
AT01965597T 2000-09-13 2001-09-13 Augentropfen ATE490761T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000277554 2000-09-13
PCT/JP2001/007928 WO2002022131A1 (fr) 2000-09-13 2001-09-13 Collyre

Publications (1)

Publication Number Publication Date
ATE490761T1 true ATE490761T1 (de) 2010-12-15

Family

ID=18762864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01965597T ATE490761T1 (de) 2000-09-13 2001-09-13 Augentropfen

Country Status (14)

Country Link
US (4) US20040097592A1 (de)
EP (1) EP1321144B1 (de)
KR (1) KR100854056B1 (de)
CN (1) CN1243548C (de)
AT (1) ATE490761T1 (de)
AU (1) AU2001286210A1 (de)
CA (1) CA2422031C (de)
CY (2) CY1113200T1 (de)
DE (1) DE60143615D1 (de)
DK (1) DK1321144T3 (de)
ES (1) ES2357551T3 (de)
NO (1) NO332650B1 (de)
PT (1) PT1321144E (de)
WO (1) WO2002022131A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE490761T1 (de) * 2000-09-13 2010-12-15 Santen Pharmaceutical Co Ltd Augentropfen
CN100591333C (zh) * 2002-08-23 2010-02-24 参天制药株式会社 以拉坦前列素为有效成分的稳定的滴眼液
US7074827B2 (en) * 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
DE602004024427D1 (de) * 2003-07-31 2010-01-14 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
WO2005044276A1 (ja) 2003-11-07 2005-05-19 Senju Pharmaceutical Co., Ltd. プロスタグランジン含有医薬組成物
JP2006187602A (ja) * 2004-12-09 2006-07-20 Santen Pharmaceut Co Ltd 分子内にフッ素原子を有するプロスタグランジン含有製品
DK1829545T3 (da) * 2004-12-24 2012-07-23 Santen Pharmaceutical Co Ltd Produkter indeholdende prostaglandin-F2alfa-derivat
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL1864666T3 (pl) 2005-03-31 2013-02-28 Agc Inc Czynnik ochronny dla komórki neuronalnej siatkówki zawierający jako składnik aktywny pochodną prostaglandyny F2 alfa
JPWO2006112313A1 (ja) 2005-04-13 2008-12-11 宇部興産株式会社 インダゾール誘導体を有効成分として含む網膜神経細胞保護剤
RU2008140298A (ru) 2006-03-13 2010-04-20 Р-Тек Уено, Лтд. (Jp) Водная композиция
FR2912207B1 (fr) * 2007-02-01 2012-10-26 Air Liquide Procede et appareil de production de monoxyde de carbone par distillation cryogenique
CN101646441B (zh) * 2007-03-29 2012-09-12 参天制药株式会社 含有氟米龙的混悬型滴眼剂
EP1985298A1 (de) * 2007-04-24 2008-10-29 Azad Pharma AG Prostaglandinhaltige Öl-in-Wasser-Emulsionen für das Auge
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
CN102014920B (zh) * 2008-04-23 2012-10-03 大塚制药株式会社 滴眼剂制剂及其应用
EP2127638A1 (de) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Verfahren und Zusammensetzung zur Behandlung von Augenhochdruck und Glaukom
US20110136898A1 (en) * 2008-08-05 2011-06-09 University College Cork, National University Of Ireland, Cork Treatment of retinal degeneration
JP2012516187A (ja) * 2009-02-20 2012-07-19 マイクロ ラブズ リミテッド 貯蔵安定性プロスタグランジン製品
EP2269575A1 (de) 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Verfahren zur Verbesserung der Bioverfügbarkeit von Latanoprost
US20110136872A1 (en) * 2009-12-09 2011-06-09 Burk Robert M Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
ES2391721T3 (es) * 2010-03-01 2012-11-29 Laboratorios Salvat, S.A. Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído
EP2452669A1 (de) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmische Zusammensetzung
EP2567689A1 (de) 2011-09-12 2013-03-13 Visiotact Pharma Ophthalmische Zusammensetzungen enhaltend Prostaglandin-F2-alpha-Derivate und Hyaluronsäure
WO2013183778A1 (ja) * 2012-06-08 2013-12-12 ライオン株式会社 粘膜用組成物
CN104288092A (zh) * 2013-07-16 2015-01-21 广东东阳光药业有限公司 拉坦前列素滴眼剂
CN104622798B (zh) * 2014-12-05 2017-12-22 广东东阳光药业有限公司 一种含有他氟前列素的滴眼液及其制备方法
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
CN110494138B (zh) 2017-03-27 2023-07-11 兴和株式会社 医药制剂
EA202190214A1 (ru) 2018-07-09 2021-04-16 Варшавске Закляды Фармацеутычне Польфа Са Офтальмологическое дозирующее устройство
BR112021005097A2 (pt) * 2018-09-21 2021-06-08 Ps Therapy Ltd. lágrima artificial, lentes de contato e composições de veículos medicinais e métodos de uso dos mesmos
JP2022512788A (ja) 2018-10-25 2022-02-07 ネクスモス カンパニー リミテッド アプタミンｃを有効成分として含む点眼液組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
EP0308135B1 (de) * 1987-09-18 1992-11-19 R-Tech Ueno Ltd. Okulare Hypotensivagenzien
JPH0662417B2 (ja) * 1987-12-25 1994-08-17 参天製薬株式会社 抗アレルギー点眼液
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
AU665287B2 (en) * 1992-12-21 1995-12-21 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
DE69714274T3 (de) * 1996-09-17 2006-06-01 Asahi Glass Co., Ltd. Fluorierte prostaglandinderivate und medikamente
JP3480549B2 (ja) * 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
AR002194A1 (es) * 1997-03-17 1998-01-07 Sanchez Reynaldo Alemany Instrumento computarizado para el analisis del movimiento.
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
CA2295512C (en) * 1998-07-14 2009-05-26 Alcon Laboratories, Inc. Prostaglandin product
AU2183900A (en) * 1998-12-24 2000-07-31 Alcon Laboratories, Inc. Ep4 receptor agonists for treatment of dry eye
ES2216509T3 (es) * 1999-01-19 2004-10-16 PHARMACIA & UPJOHN COMPANY Procedimiento de envasado para sustancias medicinales sensibles a la oxidacion.
ATE490761T1 (de) * 2000-09-13 2010-12-15 Santen Pharmaceutical Co Ltd Augentropfen
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
DE602004024427D1 (de) * 2003-07-31 2010-01-14 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Also Published As

Publication number Publication date
CN1457256A (zh) 2003-11-19
WO2002022131A1 (fr) 2002-03-21
EP1321144A4 (de) 2009-07-29
EP1321144A1 (de) 2003-06-25
ES2357551T3 (es) 2011-04-27
DK1321144T3 (da) 2011-03-07
NO20031138L (no) 2003-05-12
US20070248697A1 (en) 2007-10-25
CN1243548C (zh) 2006-03-01
PT1321144E (pt) 2011-03-10
KR100854056B1 (ko) 2008-08-26
CA2422031C (en) 2011-11-15
CY1113200T1 (el) 2014-04-09
KR20030029981A (ko) 2003-04-16
US20180353518A1 (en) 2018-12-13
CA2422031A1 (en) 2003-03-12
CY2011007I2 (el) 2015-08-05
EP1321144B1 (de) 2010-12-08
AU2001286210A1 (en) 2002-03-26
NO332650B1 (no) 2012-11-26
CY2011007I1 (el) 2014-04-09
DE60143615D1 (de) 2011-01-20
NO20031138D0 (no) 2003-03-12
US20160106757A1 (en) 2016-04-21
US20040097592A1 (en) 2004-05-20

Similar Documents

Publication Publication Date Title
ATE490761T1 (de) Augentropfen
CA2498233A1 (en) Clear ophthalmic solution comprising latanoprost as active ingredient
MX9101788A (es) Composiciones de tinta a base de agua
NO960062L (no) Farmasöytiske preparater for tungt opplöselige aktive midler
EP0766970A3 (de) Verfahren und Zusammensetzung zum Desinfizieren von Kontaktlinsen
CA2124873A1 (en) Iodine-containing corrosion inhibitor for oil field acidizing operations
DK1273299T3 (da) Minoxidilinindeholdende praparater
WO2002026277A3 (en) Stabilized hydrogen peroxide solutions
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
JP3876355B2 (ja) 点眼液
KR940005269A (ko) 비타민 e 점안제
CO5611133A2 (es) Composicion oftalmica que comprende ascomicina
DE60226836D1 (de) Stabile Elektrolytlösungen enthaltend Taurolidin
CA2137578A1 (en) Method of stabilizing preparations for contact lenses
AU2003298850A8 (en) Quaternary ammonium esters for disinfection and preservation
BR0109276A (pt) Derivados de 1,4-diamino-2-alquenil-benzeno e agentes de tingimento que contêm esses compostos
ES2166306B1 (es) Composicion desinfectante tensioactiva.
BRPI0404521A (pt) Composição herbicida
AU2001242398A1 (en) Contact lens treating method and composition
WO2003068175A1 (en) A method of cleaning a contact lens
JPH09251145A (ja) コンタクトレンズ用洗浄剤
RU98104644A (ru) Ингибитор коррозии нефтепромыслового оборудования

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1321144

Country of ref document: EP